Drug Shortage Report for LORAZEPAM
Report ID | 135885 |
Drug Identification Number | 02351080 |
Brand name | LORAZEPAM |
Common or Proper name | LORAZEPAM |
Company Name | SANIS HEALTH INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | LORAZEPAM |
Strength(s) | 1.0MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 1000 |
ATC code | N05BA |
ATC description | ANXIOLYTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-07-02 |
Actual start date | 2021-05-17 |
Estimated end date | Unknown |
Actual end date | 2024-03-01 |
Shortage status | Resolved |
Updated date | 2024-03-02 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2024-03-02 | English | Compare |
v7 | 2024-03-01 | French | Compare |
v6 | 2024-03-01 | English | Compare |
v5 | 2021-05-18 | English | Compare |
v4 | 2021-05-17 | French | Compare |
v3 | 2021-05-17 | English | Compare |
v2 | 2021-03-18 | French | Compare |
v1 | 2021-03-18 | English | Compare |
Showing 1 to 8 of 8